Paget's disease complicated by hydrocephalus and syringomyelia

British Journal of Neurosurgery

Volumn 16, Issue 5, 2002, Pages 513-516

  Raubenheimer, P J ^a   Taylor, A G ^b   Soule, S G ^b  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Basilar impression; Hydrocephalus; Paget's disease; Syringomyelia

Indexed keywords

CLODRONIC ACID; PAMIDRONIC ACID;

ADULT; ANALGESIA; ARTICLE; BASILAR ARTERY; BONE PAIN; BONE SCINTISCANNING; BONE TURNOVER; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CENTRAL CORD SYNDROME; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; HUMAN; HYDROCEPHALUS; PAGET BONE DISEASE; PRIORITY JOURNAL; SKULL RADIOGRAPHY; SYRINGOMYELIA; TREATMENT OUTCOME;

CERVICAL VERTEBRAE; FEMALE; HUMANS; HYDROCEPHALUS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OSTEITIS DEFORMANS; SYRINGOMYELIA;

EID: 0036815772     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/026886902320909178     Document Type: Article

References (22)

1. Meunier PJ, Salson C, Mathieu L, Chapuy MC, Delmas P, Alexandre C, et al. Skeletal distribution and biochemical parameters of Paget's disease. Clin Orthop 1987;217:37-44.
2. Schmidek HH. Neural dysfunction in Paget's disease of bone. Clin Orthop 1977;127:70-7.
3. Wycis HT. Basilar impression (platybasia). A case secondary to advanced Paget's disease with severe neurological manifestations: Successful surgical result. J Neurosurg 1944;1:29-30.
4. Elisevich K, Fontaine S, Bertrand G. Syringomyelia as a complication of Paget's disease. J Neurosurg 1987;67:611-13.
5. Clarke CRA, Harrison MJG. Neurologic manifestations of Paget's disease. J Neurol Sci 1978;38:171-8.
6. Bone HG, Kleerekoper M. Paget's disease of bone. J Clin Endo Metab 1992;75:1179-82.
7. Ramsay HAW, Linthicum FH. Cochlea histopathology in Paget's disease. Arch Otolaryngol 1993;14:60-1.
8. Waltner JG. Stapedectomy in Paget's disease histologic and clinical studies. Arch Otolaryngol 1965;82:355-8.
9. Khertepal U, Schuknacht HF. In search of pathologic correlates for hearing loss and vertigo in Paget's disease. A clinical and histopathological study of 26 temporal bones. Annl Otol Rhino Laryngol 1990;145(suppl):1-16.
10. Drapkin AJ. Epidural hematoma complicating Paget's disease of the skull: A case eport. Neurosurgery 1984;14:211-14.
11. Banerji NK, Millar JHD. Chiari malformation presenting in adult life. Its relationship to syringomyelia. Brain 1974;97:157-68.
12. Gardner WJ, Abdullah AF, McCormack J. The varying expressions of embryonal atresia of the fourth ventricle in adults. Arnold-Chiari malformation, Dandy-Walker syndrome, 'arachnoid' cyst of the cerebellum, and syringomyelia. J Neurosurg 1957;14:591-607.
13. Friedman P, Sklaver N, Klawens HL. Neurologic manifestations of Paget's disease of the skull. Dis Nerv Syst 1971;32:809-17.
14. Fleisch H, Russel RGG, Francis MD. Diphosphonates inhibit hydroxyapetite dissolution in vitro and bone resorption in tissue culture in vivo. Science 1969;165:1262-4.
15. Zimolo Z, Weselowski G, Rodan GA. Acid extrusion is induced by osteoclast attachment to bone: Inhibition by alendronate and calcitonin. J Clin Invest 1995;96:2277-83.
16. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 1995;10:1478-87.
17. Delmas PD, Meunier PJ. The management of Paget's disease of bone. N Engl J Med 1997;336:558-66.
18. Charhon S, Chapuy MC, Valentin-Opran A, Meunier PJ. Intravenous etidronate for spinal cord dysfunction due to paget's disease. Lancet 1982;L:391-2.
19. Chen J-R, Rhee RSC, Wallach S, Avramides A, Flores A. Neurologic disturbances in Paget's disease of bone: Response to calcitonin. Neurology 1979;29:448-57.
20. Miller PD, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ for the Paget's Risedronate/Etidronate Study Group. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Am J Med 1999;106:513-20.
21. Siris E, Weinstein RS, Altman Conte JM, Favus M, Lombardi A. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. J Clin Endocrinol Metab 1996;81:961-7.
22. Roux C, Gennari C, Farrerons J, Devogelaer JP, Mulder H, Kruse HP. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone. Arthritis Rheum 1995;38:851-8